The impact of surgical treatment and poor prognostic factors for patients with intrahepatic cholangiocarcinoma: retrospective analysis of 60 patients.
Yo Ichi Yamashita(Kyushu University), Yoshihiko Maehara(Kyushu University), Kensaku Sanefuji(Kyushu University), K Sugimachi(National Hospital Organization Kyushu Cancer Center), Tomohiro Iguchi(Fukuoka Higashi Medical Center), Hiroto Kayashima(Kyushu University), Kazutoyo Morita(Kyushu University), Akinobu Taketomi(Hokkaido University), Shigeru Ueda(Kyushu University), Takasuke Fukuhara(Hokkaido University)
PubMed
September 9, 2008
Cited by 47
Related Papers
Interleukin‐6/<scp>STAT</scp>3 signaling as a promising target to improve the efficacy of cancer immunotherapy
|Cancer Science|2017|295
Genome-wide Association Study Identifies TNFSF15 and POU2AF1 as Susceptibility Loci for Primary Biliary Cirrhosis in the Japanese Population
|The American Journal of Human Genetics|2012|272
Long‐term and perioperative outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma with propensity score matching: a multi‐institutional Japanese study
|Journal of Hepato-Biliary-Pancreatic Sciences|2015|267
Randomized phase <scp>III</scp> study of gemcitabine, cisplatin plus S‐1 versus gemcitabine, cisplatin for advanced biliary tract cancer (<scp>KHBO1401</scp>‐ <scp>MITSUBA</scp>)
|Journal of Hepato-Biliary-Pancreatic Sciences|2022|244